JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.67% |
| 2 | Technology | 15.47% |
| 3 | Financials | 11.13% |
| 4 | Healthcare | 9.58% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Molina Healthcare
MOH
$10.2B
| $68.8M | 0.01% |
253,691
-22,309
| -8% | -$5.89M |
2013 Q2
33 quarters
|
|
1027
Cracker Barrel
CBRL
$1.24B
| $68.6M | 0.01% |
490,646
+396,667
| +422% | +$55.5M |
2013 Q2
33 quarters
|
|
1028
Vanguard Morningstar Small-Cap ETF
VB
$77.6B
| $68.2M | 0.01% |
311,880
-376,639
| -55% | -$83.7M |
2013 Q2
33 quarters
|
|
1029
BridgeBio Pharma
BBIO
$12.7B
| $68.2M | 0.01% |
1,454,188
-158,767
| -10% | -$8.51M |
2019 Q2
9 quarters
|
|
1030
United Airlines
UAL
$34.9B
| $68.1M | 0.01% |
1,430,730
-1,234,998
| -46% | -$58.2M |
2013 Q2
33 quarters
|
|
|
SAVE
1031
DELISTED
Spirit Airlines, Inc.
SAVE
| $67.8M | 0.01% |
2,612,144
+22,779
| +0.9% | +$597K |
2013 Q2
33 quarters
|
|
1032
Albemarle
ALB
$12B
| $67.7M | 0.01% |
309,077
+132,336
| +75% | +$28.3M |
2013 Q2
33 quarters
|
|
1033
iShare MSCI Eurozone ETF
EZU
$9.21B
| $67.7M | 0.01% |
1,406,212
+144,952
| +11% | +$7.25M |
2013 Q4
31 quarters
|
|
|
1034
PUT
Morgan Stanley
MS
$294B
| $67.6M | 0.01% |
694,600
-68,300
| -9% | -$6.77M |
2015 Q3
24 quarters
|
|
|
RDS.B
1035
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $67.5M | 0.01% |
1,524,810
-65,757
| -4% | -$2.6M |
2013 Q2
33 quarters
|
|
|
PTVE
1036
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $67.4M | 0.01% |
5,379,607
-207,241
| -4% | -$2.81M |
2020 Q3
4 quarters
|
|
1037
Colgate-Palmolive
CL
$70.2B
| $67.3M | 0.01% |
890,370
-2,200,407
| -71% | -$175M |
2013 Q2
33 quarters
|
|
1038
Steel Dynamics
STLD
$33.6B
| $67.2M | 0.01% |
1,148,622
-259,431
| -18% | -$16.6M |
2013 Q2
33 quarters
|
|
1039
iShares Russell 3000 ETF
IWV
$20.5B
| $66.8M | 0.01% |
262,299
-35,080
| -12% | -$9.18M |
2013 Q2
33 quarters
|
|
|
DOCU
1040
PUT
DocuSign
DOCU
$13.4B
| $66.8M | 0.01% |
259,400
-95,800
| -27% | -$27.6M |
2021 Q1
2 quarters
|
|
|
ERUS
1041
DELISTED
iShares MSCI Russia ETF
ERUS
| $66.8M | 0.01% |
1,397,744
+188,824
| +16% | +$8.5M |
2013 Q2
33 quarters
|
|
1042
Herc Holdings
HRI
$4.14B
| $66.4M | 0.01% |
406,414
+12,034
| +3% | +$1.52M |
2013 Q2
33 quarters
|
|
1043
Intellia Therapeutics
NTLA
$1.77B
| $66.2M | 0.01% |
493,727
-402,850
| -45% | -$61M |
2017 Q4
15 quarters
|
|
1044
STAG Industrial
STAG
$6.92B
| $66M | 0.01% |
1,681,704
+13,499
| +0.8% | +$551K |
2015 Q4
23 quarters
|
|
1045
Xometry
XMTR
$6.1B
| $65.4M | 0.01% |
1,133,965
+260,607
| +30% | +$18.1M |
2021 Q2
1 quarter
|
|
1046
Hillman Solutions
HLMN
$1.36B
| $65M | 0.01% |
+5,450,277
| New | +$66.7M |
2021 Q3
0 quarters
|
|
|
ARNA
1047
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $65M | 0.01% |
1,091,772
+62,673
| +6% | +$3.7M |
2016 Q4
19 quarters
|
|
|
XEC
1048
DELISTED
CIMAREX ENERGY CO
XEC
| $64.9M | 0.01% |
744,229
-242,868
| -25% | -$16.9M |
2013 Q2
33 quarters
|
|
|
GCP
1049
DELISTED
GCP Applied Technologies Inc.
GCP
| $64.9M | 0.01% |
2,959,270
-498,627
| -14% | -$11.6M |
2016 Q1
22 quarters
|
|
1050
Pultegroup
PHM
$21.6B
| $64.9M | 0.01% |
1,412,342
-115,954
| -8% | -$6.03M |
2013 Q2
33 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2021 filing shows 647 new, 2,077 increased, 3,085 reduced and 500 closed positions. Its largest new stake was Toast: 2,760,295 shares worth $138M. The largest sale was Apple, an estimated $2.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 500 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.